From: Trends in antibiotic use among outpatients in New Delhi, India
Antibiotic name | Public sector | Private retail | Private clinic | |||
---|---|---|---|---|---|---|
 | DDD | %* | DDD | %* | DDD | %* |
Cephalosporins J01DA | Â | Â | Â | Â | Â | Â |
Cefuroxime | 3132 | 7.2% | 13511 | 10.8% | 8987 | 11.0% |
Cephalexin | 971 | 2.2% | Â | Â | Â | Â |
Cefixime | - | Â | 8065 | 6.4% | 5919 | 7.3% |
Cefixime + clavulanic acid | - | Â | 4127 | 3.3% | 2897 | 3.5% |
Others | 31 | Â | 7256 | Â | 3635 | Â |
Subtotal | 4134 | Â | 32959 | Â | 21929 | Â |
Fluoroquinolones J01MA | Â | Â | Â | Â | Â | Â |
Ofloxacin | 5516 | 12.7% | 15652 | 12.5% | 13222 | 16.2% |
Ciprofloxacin | 4367 | 10.1% | 7557 | 6.0% | 5434 | 6.7% |
Levofloxacin | - | Â | 5559 | 4.4% | 4586 | 5.6% |
Norfloxacin | 2590 | 6.0% | 3332 | 2.6% | 1028 | 1.3% |
Others | 86 | Â | 5639 | Â | 2750 | Â |
Subtotal | 12559 | Â | 37739 | Â | 27020 | Â |
Penicillins J01C | Â | Â | Â | Â | Â | Â |
Amoxicillin | 6403 | 14.7% | 8240 | 6.6% | 2263 | 2.8% |
Amoxicillin+Calvulinic acid | 2873 | 6.6% | 16299 | 13.0% | 14370 | 17.6% |
Amoxicillin+Cloxacillin | - | Â | 4082 | 3.2% | 3065 | 3.8% |
Ampicillin | 2234 | 5.1% | Â | Â | Â | Â |
Others | 1078 | Â | 1859 | Â | 148 | Â |
Subtotal | 12588 | Â | 30480 | Â | 19846 | Â |
Macrolides J01FA | Â | Â | Â | Â | Â | Â |
Roxithromycin | 3995 | 9.2% | 6836 | 5.4% | 3353 | 4.1% |
Azithromycin | 38 | 0.09% | 5404 | 4.3% | 3648 | 4.5% |
Erythromycin | 2286 | 5.3% | 2535 | 2.0% | 292 | 0.3% |
Others | 0 | Â | 801 | Â | 719 | Â |
Subtotal | 6319 | Â | 15576 | Â | 8012 | Â |
Tetracycline J01A | Â | Â | Â | Â | Â | Â |
Doxicycline | 4210 | 9.7% | 6147 | 4.9% | 4440 | 5.4% |
Tetracycline | 1759 | 4.0% | 949 | 0.8% | 7 | 0.008% |
Others | 15 | Â | 12 | Â | 33 | Â |
Subtotal | 5884 | Â | 7108 | Â | 4480 | Â |
Combinations of Sulfonamide with Trimethoprim (J01EE) | Â | Â | Â | Â | Â | Â |
Cotriamoxazole | 1806 | 4.0% | 1682 | 1.3% | 180 | 0.2% |
Total DDDs/1000 patients for all antibiotics | 43390 | Â | 125544 | Â | 81467 | Â |